Pharmaceutical amyloidosis associated with subcutaneous insulin and enfuvirtide administration

References

• Sipe JD, Benson MD, Buxbaum JN, Ikeda S, Merlini G, Saraiva MJ, Westermark P. Amyloid fibril protein nomenclature: 2012 recommendations from the Nomenclature Committee of the International Society of Amyloidosis. Amyloid 2012;19:167–70
   PubMed Web of Science ®Google Scholar
• Storkel S, Schneider HM, Muntefering H, Kashiwagi S. Iatrogenic, insulin-dependent, local amyloidosis. Lab Invest 1983;48:108–11
   PubMed Web of Science ®Google Scholar
• Yumlu S, Barany R, Eriksson M, Rocken C. Localized insulin-derived amyloidosis in patients with diabetes mellitus: a case report. Hum Pathol 2009;40:1655–60
   PubMed Web of Science ®Google Scholar
• Morilla ME, Kocher J, Harmaty M. Localized amyloidosis at the site of enfuvirtide injection. Ann Intern Med 2009;151:515–6
   PubMedGoogle Scholar
• D'Souza A, Theis JD, Vrana JA, Buadi F, Dispenzieri A, Dogan A. Localized insulin-derived amyloidosis: a potential pitfall in the diagnosis of systemic amyloidosis by fat aspirate. Am J Hematol 2012;87:E131–2
   PubMedGoogle Scholar
• Lavatelli F, Vrana JA. Proteomic typing of amyloid deposits in systemic amyloidoses. Amyloid 2011;18:177–82
   PubMed Web of Science ®Google Scholar
• Vrana JA, Gamez JD, Madden BJ, Theis JD, Bergen HR 3rd, Dogan A. Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens. Blood 2009;114:4957–9
   PubMed Web of Science ®Google Scholar
• Amdursky N, Gazit E, Rosenman G. Formation of low-dimensional crystalline nucleus region during insulin amyloidogenesis process. Biochem Biophys Res Commun 2012;419:232–7
   PubMedGoogle Scholar
• Landreh M, Stukenborg JB, Willander H, Soder O, Johansson J, Jornvall H. Proinsulin C-peptide interferes with insulin fibril formation. Biochem Biophys Res Commun 2012;418:489–93
   PubMedGoogle Scholar
• Bergstrom J, Murphy CL, Weiss DT, Solomon A, Sletten K, Hellman U, Westermark P. Two different types of amyloid deposits–apolipoprotein A-IV and transthyretin–in a patient with systemic amyloidosis. Lab Invest 2004;84:981–8
   PubMed Web of Science ®Google Scholar
• Klein CJ, Vrana JA, Theis JD, Dyck PJ, Dyck PJ, Spinner RJ, Mauermann ML, et al. Mass spectrometric-based proteomic analysis of amyloid neuropathy type in nerve tissue. Arch Neurol 2011;68:195–9
   PubMedGoogle Scholar
• Roden AC, Aubry MC, Zhang K, Brady JO, Levin D, Dogan A, Yi ES. Nodular senile pulmonary amyloidosis: a unique case confirmed by immunohistochemistry, mass spectrometry, and genetic study. Hum Pathol 2010;41:1040–5
   PubMedGoogle Scholar
• Martin-Rojas T, Gil-Dones F, Lopez-Almodovar LF, Padial LR, Vivanco F, Barderas MG. Proteomic profile of human aortic stenosis: insights into the degenerative process. J Proteome Res 2012;11:1537–50
   PubMedGoogle Scholar
• Stewart CR, Haw A 3rd, Lopez R, McDonald TO, Callaghan JM, McConville MJ, Moore KJ, et al. Serum amyloid P colocalizes with apolipoproteins in human atheroma: functional implications. J Lipid Res 2007;48:2162–71
   PubMed Web of Science ®Google Scholar
• Teoh CL, Griffin MD, Howlett GJ. Apolipoproteins and amyloid fibril formation in atherosclerosis. Protein Cell 2011;2:116–27
   PubMedGoogle Scholar
• Albert SG, Obadiah J, Parseghian SA, Yadira Hurley M, Mooradian AD. Severe insulin resistance associated with subcutaneous amyloid deposition. Diabetes Res Clin Pract 2007;75:374–6
   PubMed Web of Science ®Google Scholar
• Shikama Y, Kitazawa J, Yagihashi N, Uehara O, Murata Y, Yajima N, Wada R, et al. Localized amyloidosis at the site of repeated insulin injection in a diabetic patient. Intern Med 2010;49:397–401
   PubMed Web of Science ®Google Scholar
• Lasagna-Reeves CA, Clos AL, Midoro-Hiriuti T, Goldblum RM, Jackson GR, Kayed R. Inhaled insulin forms toxic pulmonary amyloid aggregates. Endocrinology 2010;151:471724
   Google Scholar
• Wang JB, Wang YM, Zeng CM. Quercetin inhibits amyloid fibrillation of bovine insulin and destabilizes preformed fibrils. Biochem Biophys Res Commun 2011;415:675–9
   PubMed Web of Science ®Google Scholar
• Wallace BJ, Tan KB, Pett SL, Cooper DA, Kossard S, Whitfeld MJ. Enfuvirtide injection site reactions: a clinical and histopathological appraisal. Australas J Dermatol 2011;52:19–26
   PubMed Web of Science ®Google Scholar
• Naujokas A, Vidal CI, Mercer SE, Harp J, Kurtin PJ, Fox LP, Thompson MM. A novel form of amyloid deposited at the site of enfuvirtide injection. J Cutan Pathol 2012;39:220–1
   PubMedGoogle Scholar